• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Universal Health Services (UHS) Sold Off On Q3 Results, Is The Stock Still Undervalued?

    Simply Wall St·10/29/2026 08:29:16
    Listen to the news

    Universal Health Services (UHS) moved into focus after its latest quarterly report, with Q3 2026 revenue of US$4.73b, Q3 net income of US$308.7m, and earnings of US$5.22 per diluted share.

    Universal Health Services shares recently traded at US$172.18, with the 1-day and 7-day share price returns declining 2.90% and 5.85% after the Q3 earnings release, as investors weighed legal settlement costs and Medicaid uncertainties against steady admissions trends and the Talkspace integration. Over a longer horizon, momentum appears mixed, with the year-to-date share price return down 21.69%, while the 3-year total shareholder return of 39.15% and 5-year total shareholder return of 41.52% indicate a stronger record for patient investors.

    Spot emerging healthcare operators reacting to earnings surprises like Universal Health Services by scanning our hand-picked 36 healthcare AI stocks for potential next movers in the sector.

    The share pullback suggests investors are reacting more to legal and Medicaid headlines than to Universal Health Services’ current operating metrics. How does that sentiment shift compare with what the valuation implies today?

    Most Popular Narrative: 31% Undervalued

    Universal Health Services last closed at $172.18, while the most followed narrative assigns a Fair Value of about $250 using a 7.51% discount rate and bullish revenue and earnings assumptions. That gap centers on how much earnings power the outpatient behavioral mix, Talkspace, and newer hospitals can add in the face of policy headwinds.

    Expanding the Thousand Branches outpatient network from 15 sites, with a plan for about 10 new centers per year, gives Universal Health Services more physical touchpoints to capture step-down and first-time behavioral patients who currently bypass hospital campuses. This can lift outpatient behavioral revenue and shift mix toward higher margin settings.

    See why 1 investors see Universal Health Services as 31% undervalued.

    The narrative applies a Fair Value of $250.02 per share, which sits well above both the current price and the consensus analyst target of $194.94, and is built on assumed annual revenue growth of about 6.5%, profit margins drifting toward 6.7%, and a 10.4x P/E in 2029. Those inputs are then discounted back using a 7.51% rate, framing Talkspace, Thousand Branches, AI tools, and faster ramping de novo facilities as the key levers that would need to offset quantified ACA and Medicaid pressures.

    Result: Fair Value of $250.02 (UNDERVALUED)

    Still, pressure on Medicaid supplemental payments and the Laurel Ridge Medicare certification issue could weigh on earnings and unsettle confidence in the Universal Health Services narrative.

    Find out about the key risks to this Universal Health Services narrative.

    Next Steps

    Sentiment on Universal Health Services is clearly divided, which is exactly why it pays to check the numbers yourself and move fast while the story is still forming. To weigh those concerns against the upside case on your own terms, start with the 3 key rewards and 1 important warning sign.

    Hunting for more Universal Health Services style ideas?

    Do not stop with Universal Health Services. Broader context sharpens judgment, and fresh ideas from other corners of the market can reshape how this stock looks in your portfolio.